Abstract:Background: The GABRA1 gene, encoding the GABR A R subunit α1, plays vital roles in inhibitory neurons. Previously, the GABRA1 gene has been identified to be associated with developmental and epileptic encephalopathy (DEE) and idiopathic generalized epilepsy (IGE). This study aims to explore the phenotypic spectrum of GABRA1 and molecular subregional effect analysis. Methods: Trios-based whole-exome sequencing was performed in patients with epilepsy. Previously reported GABRA1 mutations were systematically reviewed to analyze the molecular subregional effects. Results: De novo GABRA1 mutations were identified in six unrelated patients with heterogeneous epilepsy, including three missense mutations (p.His83Asn, p.Val207Phe, and p.Arg214Cys) and one frameshift mutation (p.Thr453Hisfs*47). The two missense mutations, p.His83Asn and p.Val207Phe, were predicted to decrease the protein stability but no hydrogen bond alteration, with which the two patients also presented with mild genetic epilepsy with febrile seizures plus and achieved seizure-free status by monotherapy. The missense variant p.Arg214Cys was predicted to decrease protein stability and destroy hydrogen bonds with surrounding residues, which was recurrently identified in three cases with severe DEE. The frameshift variant p.Thr453Hisfs*47 was located in the last fifth residue of the C-terminus and caused an extension of 47 amino acids, with which the patients presented with moderated epilepsy with generalized tonic-clonic seizures alone (GTCA) but achieved seizure-free status by four drugs. The four variants were not presented in gnomAD and were evaluated as "pathogenic/likely pathogenic" according to ACMG criteria. Analysis of all reported cases indicated that patients with mutations in the N-terminal extracellular region presented a significantly higher percentage of FS and DEE, and the patients with variants in the transmembrane region presented earlier seizure onset ages. Significance: This study suggested that GABRA1 variants were potentially associated with a spectrum of epilepsies, including EFS+, DEE, and GTCA. Phenotypic severity may be associated with the damaging effect of variants. The molecular subregional effects help in understanding the underlying mechanism of phenotypic variation.

DLG3 variants caused X-linked epilepsy with/without neurodevelopmental disorders and the genotype-phenotype correlation

Clinical and Molecular Analysis of Epilepsy-Related Genes in Patients with Dravet Syndrome

ZFHX3 variants cause childhood partial epilepsy and infantile spasms with favourable outcomes

CCDC22 variants caused X-linked focal epilepsy and focal cortical dysplasia

<i>SZT2</i> variants associated with partial epilepsy or epileptic encephalopathy and the genotype-phenotype correlation

De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects

Gene Mutational Analysis in a Cohort of Chinese Children with Unexplained Epilepsy: Identification of a New KCND3 Phenotype and Novel Genes Causing Dravet Syndrome

CCDC88C variants are associated with focal epilepsy and genotype–phenotype correlation

Novel Mutations and Phenotypes of Epilepsy-Associated Genes in Epileptic Encephalopathies.

The Clinical Phenotypes and Genetic Characteristics of Seven Epilepsy Patients Related to Heterozygous DEPDC5 Variants in China

De novo variants in KCNJ3 are associated with early-onset epilepsy

DYNC1H1‐related Epilepsy: Genotype–phenotype Correlation

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

DEPDC5 plays a vital role in epilepsy: Genotypic and phenotypic features in cohort and literature

Genetic Variants Identified from Epilepsy of Unknown Etiology in Chinese Children by Targeted Exome Sequencing

GRIN2A Variants Associated with Idiopathic Generalized Epilepsies.

Functional Characterization of Novel NPRL3 Mutations Identified in Three Families with Focal Epilepsy.

Genetic Diagnosis Spectrum and Multigenic Burden of Exome-Level Rare Variants in a Childhood Epilepsy Cohort

Analysis of epilepsy-associated variants in HCN3 - Functional implications and clinical observations

CSMD1 is a causative gene of developmental and epileptic encephalopathy and generalized epilepsies

Large De Novo Microdeletion in Epilepsy with Intellectual and Developmental Disabilities, with a Systems Biology Analysis.